Physician profile
Julia Frederick
NPI 1750166971
$2,137.91
in general payments reported to CMS, 2019-2025
36 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $642 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,070 · Education: $67.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,070.34 |
| Education | $67.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $274.83 | 2024-2025 | Repatha, Repatha, Krystexxa |
| Ardelyx, INC. | $193.67 | 2025 | Ibsrela |
| Novo Nordisk INC | $132.24 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Apellis Pharmaceuticals, INC. | $113.12 | 2025 | Empaveli |
| Astrazeneca Pharmaceuticals LP | $107.23 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $98.32 | 2024 | Mounjaro |
| Veloxis Pharmaceuticals, INC. | $94.66 | 2025 | Envarsus |
| Glaxosmithkline, LLC. | $83.48 | 2024-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Aimmune Therapeutics, INC. | $80.96 | 2025 | Zenpep, Vowst |
| Radius Health, INC. | $79.41 | 2024-2025 | Tymlos |
| Calliditas Therapeutics US INC. | $75.00 | 2025 | Tarpeyo |
| Vifor Pharma, INC. | $74.44 | 2025 | Veltassa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.42 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $53.08 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $42.64 | 2024-2025 | Tryvio, Quviviq |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $42.14 | 2024-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $39.66 | 2024-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $39.05 | 2024-2025 | General - Therapies, Watchman Flx |
| Almatica Pharma LLC | $35.04 | 2024 | Loreev Xr |
| Pfizer INC. | $33.31 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $32.86 | 2025 | |
| Janssen Pharmaceuticals, INC | $31.19 | 2024 | Spravato, Xarelto |
| Mallinckrodt Hospital Products INC. | $29.52 | 2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $26.78 | 2024 | Evkeeza |
| Fresenius USA Marketing, INC. | $26.69 | 2025 | Velphoro |
| Takeda Pharmaceuticals U.S.A., INC. | $26.68 | 2024 | Gattex |
| Abiomed | $26.38 | 2025 | |
| Sumitomo Pharma America, INC. | $24.02 | 2024 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $23.41 | 2024 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $23.24 | 2025 | Jynarque |
| Abbvie INC. | $23.21 | 2024 | |
| Alexion Pharmaceuticals, INC. | $21.71 | 2025 | Ultomiris |
| Tolmar, INC. | $16.67 | 2024 | |
| Scpharmaceuticals INC. | $15.77 | 2025 | |
| Lundbeck LLC | $14.88 | 2025 | Rexulti |
| Opko Pharmaceuticals, LLC | $14.20 | 2025 | Rayaldee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.